The Paper Is A Blast, And I Want A Specific Crossover With Abbott Elementary Hear me out. Cinemablend · Nov 15, 2025
The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep? Stocks dropped hard last week, but a late-day rally on Friday staved off the worst. The Dow Jones Industrial Average held up the best, only closing down 1.21%. The SP 500 was down 1.63%, but the Nasdaq suffered the most, as it closed down 3.04%. Tech was routed hard as… Benzinga · Nov 10, 2025
Preliminary tests find germ that causes botulism in ByHeart baby formula California health officials say tests showed that ByHeart baby formula linked to a botulism outbreak contained the type of bacteria that produces the toxin that has sickened at least 13 infants in 10 states The Independent UK · Nov 9, 2025
Abbott Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? Despite underperforming the broader market over the past year, Wall Street analysts remain highly bullish on Abbott Laboratories' long-term outlook. Barchart · Nov 6, 2025
5 Dividend Aristocrats Proving That Reliability Still Pays in 2025 These five companies offer stability in terms of growth and income. Barchart · Oct 17, 2025
Abbott Laboratories' October Price Plunge Is a Signal to Buy Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend. MarketBeat · Oct 17, 2025
Analyst Sees Noise In Q3 P&L, Affirms Abbott's Medtech Strength Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance. Benzinga · Oct 16, 2025
These Analysts Revise Their Forecasts On Abbott Following Q3 Results Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter and narrowed fiscal 2025 guidance on Wednesday. Benzinga · Oct 16, 2025
Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations Abbott Laboratories (NYSE:ABT) stock fell after the company reported muted sales in the third quarter and narrowed fiscal 2025 guidance. Benzinga · Oct 15, 2025
Abbott Elementary's Season 5 Premiere Had A Lot Of Moving And Shaking, And I Need To Talk About One Specific Change Well, this will be fun! Cinemablend · Oct 2, 2025
What to Expect From Abbott Laboratories' Next Quarterly Earnings Report Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth. Barchart · Sep 29, 2025
Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga · Sep 18, 2025
3 Dividend Kings That Pay - and Beat the Market Too These Dividend Kings are outperforming the S&P 500 in 2025 while extending decades of payout growth and earning strong buy ratings. Barchart · Sep 12, 2025
Quinta Brunson Said Abbott Elementary's Season 5 Christmas Episode Will Be 'A Game Changer,' And I Have A Few Wild Guesses About Why Hear me out... Cinemablend · Aug 28, 2025
Cinemablend · Aug 19, 2025 Why Abbott Elementary Doesn’t Want To Go ‘The Easy Route’ With Janine And Gregory’s Relationship In Season 5 Janine and Gregory fans can celebrate!
Barchart · Aug 11, 2025 Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink? As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Sports Illustrated · Jul 25, 2025 ‘A Goal of Ours’—U.S. Soccer Standouts Talk Growth of Game Ahead of PL Summer Series Tyler Adams and Tim Howard spoke to Sports Illustrated about the growth of soccer in the U.S.
Barchart · Jul 22, 2025 3 Dividend Stocks With 100+ Years of History and Sky-High Growth These three century-old companies boast strong buy ratings, 50%+ dividend growth, and rock-solid fundamentals—ideal picks for long-term income investors.
MarketBeat · Jul 18, 2025 Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.
Benzinga · Jul 18, 2025 These Analysts Revise Their Forecasts On Abbott Following Q2 Results Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but dialed back earnings and growth projections for the rest of the year.
Benzinga · Jul 17, 2025 Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors Abbott Laboratories (NYSE:ABT) reported better-than-expected sales and profits in the second quarter, but the stock still plummeted nearly 10% after management dialed back earnings and growth projections for the rest of the year.
Benzinga · Jul 17, 2025 Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.
Benzinga · Jul 16, 2025 Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Abbott Laboratories (NYSE:ABT) will release earnings results for the second quarter, before the opening bell on Thursday, July 17.
Cinemablend · Jul 10, 2025 Always Sunny In Philadelphia's Gang Was Back At Their Worst In The Abbott Elementary Crossover, But Quinta Brunson Shocked Me With The Biggest Spit Take Moment Quinta Brunson's Janine vs. Kaitlin Olson's Dee!
BANG Premier · Jul 1, 2025 Quinta Brunson: Abbott Elementary cast would 'love to pursue other projects' Quinta Brunson feels "blessed" that Abbott Elementary is still popular but admitted she's looking forward to a different role in the future.